Domperidone Maleate

马来酸多潘立酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDomperidone Maleate
Drug Alias Name多潘立酮马来酸盐domperidonadomperidonumDomperidNauzelin +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsNauseaDyspepsiaBreast Neoplasms
Global Approved IndicationsNauseaDyspepsia
Approved Indications in ChinaNauseaDyspepsia
Original Approved Country/TerritoryMainland China
Original Approved Date2005/01/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesGenor Biopharma Co Ltd
Active IndicationsNauseaDyspepsia
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeA03FA03
Related LinksWikipediaDrugBankKEGG